Hospital
Athens Regional Medical Center LLC
Athens Regional Medical Center LLC was paid $12.22M by Medicaid between Jan 2018 and Dec 2024, across 108 billing codes. Its largest line is 99283, emergency room visit (moderate) — 26% of everything it billed.
33Billing provider infoATHENS REGIONAL MEDICAL CENTER LLC
ATHENS, TN 37303
ATHENS, TN 37303
33aNPI1669567319assigned 10/04/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$12.22M
24GClaims346,597
24DCodes billed108
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Tennessee
Rank by total paid#25 of 71
Median peer was paid$6.96M
This provider vs. median1.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 55,509 | $1.99M | |
| 2019 | 58,186 | $2.06M | |
| 2020 | 48,460 | $1.53M | |
| 2021 | 49,539 | $1.70M | |
| 2022 | 52,488 | $1.82M | |
| 2023 | 51,231 | $1.78M | |
| 2024incomplete | 31,184 | $1.34M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 26% | 41,608 | 35,926 | $3.17M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 23% | 31,883 | 25,675 | $2.81M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 6.8% | 12,787 | 10,794 | $836K |
| 96361 | Intravenous infusion, hydration; each additional hour | 6.6% | 7,640 | 6,263 | $801K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.6% | 5,302 | 4,157 | $568K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.7% | 13,006 | 10,018 | $447K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.5% | 6,904 | 6,236 | $426K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2.5% | 5,161 | 4,651 | $309K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.1% | 9,639 | 8,238 | $260K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.9% | 40,058 | 29,988 | $232K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.8% | 7,354 | 6,012 | $224K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.8% | 2,781 | 2,279 | $219K |
96 more codes
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.3% | 4,147 | $158K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.2% | 3,101 | $147K |
| 80053 | Comprehensive metabolic panel | <1% | 23,730 | $117K |
| 0240U | <1% | 1,489 | $113K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 2,581 | $113K |
| 84484 | <1% | 7,723 | $110K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 2,129 | $109K |
| 59025 | Fetal non-stress test | <1% | 1,289 | $104K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 6,374 | $102K |
| 71045 | Radiologic examination, chest; single view | <1% | 8,285 | $89K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 6,808 | $60K |
| G0378 | Hospital observation service, per hour | <1% | 410 | $50K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 3,177 | $50K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,717 | $49K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,507 | $46K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 445 | $45K |
| 87430 | <1% | 3,536 | $40K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 346 | $39K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 170 | $35K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 9,221 | $35K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 353 | $35K |
| 81001 | <1% | 23,874 | $33K | |
| 83690 | <1% | 5,197 | $33K | |
| 95811 | <1% | 147 | $22K | |
| 81025 | <1% | 3,792 | $18K | |
| 87081 | <1% | 2,372 | $17K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 728 | $16K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,170 | $15K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 215 | $12K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 172 | $9K |
| 97597 | <1% | 237 | $9K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 277 | $8K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,490 | $8K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 486 | $6K |
| 85018 | <1% | 815 | $5K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,362 | $5K |
| 36416 | <1% | 722 | $4K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 123 | $4K |
| 83880 | <1% | 407 | $4K | |
| 83655 | <1% | 102 | $4K | |
| 83605 | <1% | 540 | $3K | |
| 82150 | <1% | 592 | $3K | |
| 96367 | <1% | 27 | $3K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 3,053 | $3K |
| 87040 | <1% | 280 | $2K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,262 | $2K |
| 85730 | <1% | 652 | $2K | |
| 87186 | <1% | 224 | $2K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 7,590 | $2K |
| 87807 | <1% | 111 | $1K | |
| 85610 | <1% | 711 | $1K | |
| 82728 | <1% | 248 | $1K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 26 | $1K |
| 83550 | <1% | 273 | $964.29 | |
| 87077 | <1% | 224 | $916.82 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,666 | $862.47 |
| 82077 | <1% | 27 | $717.55 | |
| 83540 | <1% | 273 | $685.48 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 15 | $660.66 |
| 82550 | <1% | 206 | $643.35 | |
| 83735 | <1% | 131 | $603.17 | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 77 | $584.32 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 88 | $570.54 |
| 84702 | <1% | 31 | $555.84 | |
| 85379 | <1% | 35 | $380.95 | |
| 83615 | <1% | 314 | $375.95 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 347 | $327.00 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 28 | $325.88 |
| 86140 | <1% | 87 | $316.81 | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 27 | $296.42 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 26 | $294.98 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 234 | $255.12 |
| 85652 | <1% | 100 | $175.94 | |
| 82962 | <1% | 83 | $161.22 | |
| 80061 | Lipid panel | <1% | 45 | $144.22 |
| 87210 | <1% | 39 | $135.34 | |
| 73630 | <1% | 14 | $130.71 | |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 13 | $121.76 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 153 | $104.59 |
| 82553 | <1% | 67 | $100.26 | |
| 82607 | <1% | 62 | $98.50 | |
| 82805 | <1% | 14 | $91.01 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 70 | $73.78 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 97 | $73.11 |
| 82746 | <1% | 47 | $50.85 | |
| 85027 | <1% | 16 | $14.84 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 225 | $12.09 |
| 84439 | <1% | 16 | $10.38 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 88 | $8.96 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 184 | $7.56 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 12 | $5.60 |
| A9270 | Non-covered item or service | 0% | 197 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 172 | $0.00 |
| 87070 | 0% | 47 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 25 | $0.00 |
| 85014 | 0% | 37 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLAWRENCE, CHARLOTTE (SECRETARY)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.